363
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Reaction targets of antioxidants in azo-initiator or lipid hydroperoxide induced lipid peroxidation

, &
Pages 301-310 | Received 05 Mar 2020, Accepted 20 Apr 2020, Published online: 13 May 2020

References

  • Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic Biol Med. 2009;47(5):469–484.
  • Yin HY, Xu LB, Porter NA. Free radical lipid peroxidation: mechanisms and analysis. Chem Rev. 2011;111(10):5944–5972.
  • Poter NA. Mechanisms for the oxidation of polyunsaturated lipids. Acc Chem Res. 1986;19(9):262–268.
  • Ayala A, Munoz MF, Arguelles S. Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev. 2014;2014:360438.
  • Cheng ZY, Li YZ. What is responsible for the initiating chemistry of iron-mediated lipid peroxidation: an update. Chem Rev. 2007;107(3):748–766.
  • Dixon SJ, Lemberg KM, Lamprecht MR, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149(5):1060–1072.
  • Kagan VE, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat Chem Biol. 2017;13(1):81–90.
  • Schopfer FJ, Cipollina C, Freeman BA. Formation and signaling actions of electrophilic lipids. Chem Rev. 2011;111(10):5997–6021.
  • Gueraud F, Atalay M, Bresgen N, et al. Chemistry and biochemistry of lipid peroxidation products. Free Radic Res. 2010;44(10):1098–1124.
  • Kaur K, Salomon RG, O’Neil J, et al. (Carboxyalkyl)pyrroles in human plasma and oxidized low-density lipoproteins. Chem Res Toxicol. 1997;10(12):1387–1396.
  • Reed TT. Lipid peroxidation and neurodegenerative disease. Free Radic Biol Med. 2011;51(7):1302–1319.
  • Firuzi O, Miri R, Tavakkoli M, et al. Antioxidant therapy: current status and future prospects. Curr Med Chem. 2011;18(25):3871–3888.
  • Sanyal AJ, Chalasani N, Kowdley KV, et al. Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N Engl J Med. 2010;362(18):1675–1685.
  • Otomo E, Tohgi H, Kogure K, et al. Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction – randomized, placebo-controlled, double-blind study at multicenters. Cerebrovasc Dis. 2003;15(3):222–229.
  • Rothstein JD. Edaravone: a new drug approved for ALS. Cell. 2017;171(4):725–726.
  • Friedmann Angeli JP, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice. Nat Cell Biol. 2014;16(12):1180–1191.
  • Fang XX, Wang H, Han D, et al. Ferroptosis as a target for protection against cardiomyopathy. Proc Natl Acad Sci U S A. 2019;116(7):2672–2680.
  • Tuo QZ, Lei P, Jackman KA, et al. Tau-mediated iron export prevents ferroptotic damage after ischemic stroke. Mol Psychitr. 2017;22(11):1520–1530.
  • Miotto G, Rossetto M, Di Paolo ML, et al. Insight into the mechanism of ferroptosis inhibition by ferrostatin-1. Redox Biol. 2019;28(101328):101328.
  • Cao G, Alessio HM, Cutler RG. Oxygen-radical absorbance capacity assay for antioxidants. Free Radic Biol Med. 1993;14(3):303–311.
  • Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239(1):70–76.
  • Huang DJ, Ou BX, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem. 2005;53(6):1841–1856.
  • Yamada K, Mito F, Matsuoka Y, et al. Fluorescence probes to detect lipid-derived radicals. Nat Chem Biol. 2016;12(8):608–613.
  • Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911–917.
  • Barclay LRC, Locke SJ, Macneil JM, et al. Autoxidation of micelles and model membranes – quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants. J Am Chem Soc. 1984;106(8):2479–2481.
  • Marnett LJ. Lipid peroxidation-DNA damage by malondialdehyde. Mutat Res. 1999;424(1–2):83–95.
  • Gardner HW. Oxygen radical chemistry of polyunsaturated fatty acids. Free Radic Biol Med. 1989;7(1):65–86.
  • Mugesh G, Du Mont WW, Sies H. Chemistry of biologically important synthetic organoselenium compounds. Chem Rev. 2001;101(7):2125–2179.
  • Qian SY, Yue GH, Tomer KB, et al. Identification of all classes of spin-trapped carbon-centered radicals in soybean lipoxygenase-dependent lipid peroxidations of omega-6 polyunsaturated fatty acids via LC/ESR, LC/MS, and tandem MS. Free Radic Biol Med. 2003;34(8):1017–1028.
  • Qian SY, Wang HP, Schafer FQ, et al. EPR detection of lipid-derived free radicals from PUFA, LDL, and cell oxidations. Free Radic Biol Med. 2000;29(6):568–579.
  • Gryn’ova G, Ingold KU, Coote ML. New insights into the mechanism of amine/nitroxide cycling during the hindered amine light stabilizer inhibited oxidative degradation of polymers. J Am Chem Soc. 2012;134(31):12979–12988.
  • Haidasz EA, Meng D, Amorati R, et al. Acid is key to the radical-trapping antioxidant activity of nitroxides. J Am Chem Soc. 2016;138(16):5290–5298.
  • Brigelius-Flohe R, Traber MG. Vitamin E: function and metabolism. Faseb J. 1999;13(10):1145–1155.
  • Yamamoto Y, Kuwahara T, Watanabe K. Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one. Redox Rep. 1996;2(5):333–338.
  • Noguchi N, Yoshida Y, Kaneda H, et al. Action of ebselen as an antioxidant against lipid peroxidation. Biochem Pharmacol. 1992;44(1):39–44.
  • Poon JF, Pratt DA. Recent insights on hydrogen atom transfer in the inhibition of hydrocarbon autoxidation. Acc Chem Res. 2018;51(9):1996–2005.
  • Zilka O, Shah R, Li B, et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent Sci. 2017;3(3):232–243.
  • Skouta R, Dixon SJ, Wang JL, et al. Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models. J Am Chem Soc. 2014;136(12):4551–4556.
  • Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931–947.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.